Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1984;82(1):19–29. doi: 10.1007/BF01309365

The biological relationship of mouse hepatitis virus (MHV) strains and interferon:In vitro induction and sensitivities

L E Garlinghouse Jr 1,2, A L Smith 1,2, T Holford 2
PMCID: PMC7087025  PMID: 6208879

Summary

Five prototype strains of mouse hepatitis virus (MHV) -1,-3, -S,- A59 and -JHM were analyzed for their ability to induce interferon (IFN) in seven cell lines of rodent origin. Induction of IFN by all of the prototype MHV strains was infrequent and unpredictable, while IFN was produced consistently by five cell lines treated with known inducers. Priming and/or aging of cells did not enhance IFN induction by the MHV strains except in the case of MHV-A59 which consistently induced moderate levels of IFN on L-cells which were both primed and aged. Kinetic studies of MHV-A59-induced IFN on primed and aged L-cells demonstrated that detectable levels of IFN were not produced until 24 hours post-inoculation (p.i.). Peak levels were attained at 30 hours p.i. with no additional IFN produced through 48 hours p.i. MHV-induced IFN was similar in composition and properties to Newcastle disease virus-induced IFN.

The sensitivities of the five MHV strains to eight concentrations of preformed L-cell IFN were also assessed. All strains except MHV-S fit a linear model with MHV-3, MHV-A59 and MHV-JHM having similar slopes. At most concentrations MHV-3 was less sensitive than MHV-1, -A59 or -JHM to IFN. The response curve for MHV-S was non-linear. This strain was more sensitive to the antiviral effects of the pre-formed IFN except at the highest concentrations of IFN used.

Keywords: Hepatitis, Infectious Disease, Linear Model, Interferon, Response Curve

Footnotes

With 1 Figure

References

  • 1.Abreu S. L., Banoroft F. C., Stewart W. E., II Interferon Priming effects on interferon messenger RNA. J. Biol. Chem. 1978;254:4114–4118. [PubMed] [Google Scholar]
  • 2.Bang F. B., Warwick A. Mouse macrophages as host cells for the mouse hepatitis virus and the genetic base of their susceptibility. Proc. Nat. Acad. Sci. U.S.A. 1960;46:1065–1075. doi: 10.1073/pnas.46.8.1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Baron S., Dianzani F., Stanton G. J. The interferon system: A review to 1982—Part 1. Texas Rept. on Biol. Med. 1982;41:64–98. [PubMed] [Google Scholar]
  • 4.Cantell K., Pauker K. Quantitative studies on viral interference in suspended L-cells. IV. Production and assay of interferon. Virology. 1963;21:11–21. doi: 10.1016/0042-6822(63)90298-8. [DOI] [PubMed] [Google Scholar]
  • 5.Dubois-Dalcq M. E., Doller E. W., Haspel M. V., Holmes K. V. Cell tropism and expression of mouse hepatitis viruses (MHV) in mouse spinal cord cultures. Virology. 1982;119:317–331. doi: 10.1016/0042-6822(82)90092-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Goto N., Hirano N., Aivchi M., Hayashi T., Fujiwara K. Nasoencephalopathy of mice infected intranasally with a mouse hepatitis virus, JHM strain. Jpn. J. Exp. Med. 1977;47:59–64. [PubMed] [Google Scholar]
  • 7.Hirano N., Goto N., Makino S., Fujiwara K. Persistent infection with mouse hepatitis virus, JHM strain in DBT cell culture. Adv. Exp. Med. Biol. 1981;142:301–308. doi: 10.1007/978-1-4757-0456-3_24. [DOI] [PubMed] [Google Scholar]
  • 8.Hsiung G. D., Fong C. K. Y. Diagnostic Virology. New Haven: Yale Press; 1982. pp. 245–251. [Google Scholar]
  • 9.Kawade Y., Yamamoto Y. Induction and production of L-cell interferon. Meth. Enzymol. 1981;78:139–143. doi: 10.1016/0076-6879(81)78107-2. [DOI] [PubMed] [Google Scholar]
  • 10.Kawai A., Matsumoto S., Tanabe K. Characterization of rabies viruses recovered from persistently infected BHK cells. Virology. 1975;67:520–533. doi: 10.1016/0042-6822(75)90452-3. [DOI] [PubMed] [Google Scholar]
  • 11.Knobler R. L., Haspel M. V., Oldstone M. B. A. Mouse hepatitis virus type 4 (JHM strain)-induced fatal central nervous system disease. J. Exp. Med. 1981;153:832–843. doi: 10.1084/jem.153.4.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Kraft L. M. Viral diseases of the digestive system. In: Foster H. L., Small J. D., Fox J. G., editors. The Mouse in Biomedical Research, Vol. II: Diseases. New York: Academic Press; 1982. pp. 159–193. [Google Scholar]
  • 13.Kronenberg L. H., Friedman T. Relative quantitative assay on the biological activity of interferon messenger RNA. J. gen. Virol. 1975;27:225–232. doi: 10.1099/0022-1317-27-2-225. [DOI] [PubMed] [Google Scholar]
  • 14.MacNaughton M. R., Patterson S. Mouse hepatitis virus strain 3 infection of C57, A/Sn and A/J strain mice and their macrophages. Arch. Virol. 1980;66:71–75. doi: 10.1007/BF01315046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Morgensen S. C. Role of macrophages in natural resistance to virus infections. Microbiol. Rev. 1979;43:1–26. doi: 10.1128/mr.43.1.1-26.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Pickel K., Muller M. A., ter Meulen V. Analysis of age-dependent resistance to murine coronavirus JHM infection in mice. Infect. Immun. 1981;34:648–654. doi: 10.1128/iai.34.3.648-654.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Reed J., Muench H. A simple method of estimating fifty percent end points. Am. J. Hyg. 1938;27:493–496. [Google Scholar]
  • 18.Robb J. A., Bond C. W. Coronaviridae. In: Fraenkel-Conrat H., Wagner R. R., editors. Comprehensive Virology, Vol. 14. New York: Plenum Press; 1979. pp. 193–247. [Google Scholar]
  • 19.Rubinstein S., Familletti P. C., Pestka S. Convenient assay for interferons. J. Virol. 1981;37:755–758. doi: 10.1128/jvi.37.2.755-758.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.SAS Institute Inc . SAS User's Guide: Statistics. Cary, N.C.: SAS Institute Inc.; 1982. [Google Scholar]
  • 21.Schindler L., Engler H., Kirchner H. Activation of natural killer cells and induction of interferon after injection of mouse hepatitis virus type 3 in mice. Infect. Immun. 1982;35:869–873. doi: 10.1128/iai.35.3.869-873.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Schmidt N. J. Cell culture techniques for diagnostic virology. In: Lennette E. H., Schmidt W. V., editors. Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections. 5th ed. Washington, D.C.: American Public Health Association; 1979. pp. 65–140. [Google Scholar]
  • 23.Siddel S., Wege H., ter Meulen V. The biology of coronaviruses. J. gen. Virol. 1983;64:761–776. doi: 10.1099/0022-1317-64-4-761. [DOI] [PubMed] [Google Scholar]
  • 24.Smith A. L., Tignor G. H. Host cell receptors for two strains of Sindbis virus. Arch. Virol. 1980;66:11–26. doi: 10.1007/BF01315041. [DOI] [PubMed] [Google Scholar]
  • 25.Stewart W. E., II, Gosser L. B., Lockert R. Z., Jr. Distinguishing characteristics of the interferon responses of primary and continuous mouse cell cultures. J. gen. Virol. 1971;13:35–50. doi: 10.1099/0022-1317-13-1-35. [DOI] [PubMed] [Google Scholar]
  • 26.Stohlman S. A., Weiner L. P. Stability of neurotropic mouse hepatitis virus (JHM strain) during chronic infection of neuroblastoma cells. Arch. Virol. 1978;57:53–61. doi: 10.1007/BF01315637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Stohlman S. A., Sakaguchi A. Y., Hiti A. Interferon production and activity in mouse neuroblastoma cells. Arch. Virol. 1978;57:91–96. doi: 10.1007/BF01315640. [DOI] [PubMed] [Google Scholar]
  • 28.Stohlman S. A., Frelinger J. A., Weiner L. P. Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM-II. Adherent cell-mediated protection. J. Immunol. 1980;124:1733–1739. [PubMed] [Google Scholar]
  • 29.Stohlman S. A., Brayton P. R., Harmon R. C., Stevenson D., Ganges R. G., Matsushima G. K. Natural killer cell activity during mouse hepatitis virus infection: Response in the absence of interferon. Intl. J. Cancer. 1983;31:309–314. doi: 10.1002/ijc.2910310310. [DOI] [PubMed] [Google Scholar]
  • 30.Virelizier J. L., Dayan A. D., Allison A. C. Neuropathological effects of persistent infection of mice by mouse hepatitis virus. Infect. Immun. 1975;12:1127–1140. doi: 10.1128/iai.12.5.1127-1140.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Virology are provided here courtesy of Nature Publishing Group

RESOURCES